Molgeom Uno (Molsidomine)

Molsidomine, the active ingredient in Molgeom Uno, is a nitric oxide donor presented as a tablet for oral use. It is used to treat stable angina pectoris by improving myocardial oxygen balance in adult patients. GNH USA supplies Molgeom Uno as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Molsidomine is indicated for conditions involving myocardial oxygen demand and coronary blood flow. - Stable angina pectoris: reduces the frequency and severity of chest pain episodes. - Chronic stable angina: improves exercise tolerance and delays onset of angina during exertion. - Angina prophylaxis: helps prevent anginal attacks in patients with known coronary artery disease.

Molsidomine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Flushing: sensation of warmth and redness, usually short‑lived. - Dizziness or light‑headedness: related to blood pressure changes. - Nausea: occasional gastrointestinal upset. - Hypotension: mild reduction in blood pressure, especially on standing. - Tachycardia: compensatory increase in heart rate.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Allergic reactions: rash, pruritus, or anaphylaxis in rare cases. - Myocardial infarction: rare but reported in patients with pre‑existing cardiac disease. - Severe bradycardia: unusually low heart rate needing intervention. - Hepatic dysfunction: abnormal liver enzymes or hepatitis. - Blood dyscrasias: rare cases of neutropenia or thrombocytopenia.

Before initiating molsidomine therapy, consider the following safety measures. - Blood pressure monitoring: check baseline and periodic readings to avoid excessive hypotension. - Severe hypotension avoidance: do not use in patients with already low blood pressure. - Hepatic impairment caution: adjust use in patients with liver disease. - Drug interaction assessment: review concomitant vasodilators and antihypertensives. - Pregnancy safety: use only if the potential benefit justifies the potential risk, as data are limited. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Molsidomine can interact with several medication classes, requiring careful management.

Major Interactions (Avoid): - Nitrates (e.g., nitroglycerin): additive vasodilation may cause severe hypotension. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): risk of profound blood pressure fall.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (beta‑blockers, ACE inhibitors, ARBs): may enhance blood‑pressure‑lowering effect. - Diuretics: combined effect on volume status may increase hypotensive risk. - Alcohol: can potentiate vasodilatory effects and dizziness. - Other nitric‑oxide donors: additive vasodilatory action requires monitoring.